Predictmedix Inc (PMED.CX)
0.14
-0.01
(-6.67%)
CAD |
CNSX |
Mar 20, 15:59
Key Stats
| Price and Performance | |
|---|---|
| Market Cap | 17.09M |
| 52 Week High (Daily) | Upgrade |
| 52 Week Low (Daily) | Upgrade |
| All-Time High (Daily) | Upgrade |
| Year to Date Total Returns (Daily) | Upgrade |
| 1 Month Total Returns (Daily) | Upgrade |
| 1 Year Total Returns (Daily) | 7.14% |
| Valuation | |
| PE Ratio | -- |
| PE Ratio (Forward) | Upgrade |
| PS Ratio | 239.38 |
| Price to Book Value | 51.82 |
| EV to EBITDA | Upgrade |
| Dividend | |
|---|---|
| Dividend | -- |
| Dividend Yield (Forward) | Upgrade |
| Financials | |
| Revenue (5 Year Growth) | Upgrade |
| Revenue (Quarterly YoY Growth) | Upgrade |
| EPS Diluted (5 Year Growth) | Upgrade |
| EPS Diluted (Quarterly YoY Growth) | Upgrade |
| Debt to Equity Ratio | 0.00 |
| Return on Equity | Upgrade |
| Return on Assets | Upgrade |
| Risk | |
| Beta (5Y) | Upgrade |
| Max Drawdown (5Y) | -- |
News
Headline
Wire
Time (ET)
Accesswire
03/15 07:00
Accesswire
03/08 07:00
Accesswire
03/06 07:00
Accesswire
02/15 07:30
Accesswire
02/13 08:01
Accesswire
01/16 08:00
Accesswire
11/17 08:31
Accesswire
11/07 08:31
Earnings
Profile
Edit
| Predictmedix Inc, through its subsidiaries, is in the business of investment in technology to detect if an individual is under the influence of cannabis and to predict substance addiction. It is currently focusing on artificial intelligence technologies, which are targeting two specific areas: workplace health & safety and healthcare. Its solutions include Infectious Disease Screening, Cannabis & Alcohol Impairment Screening, and Mobilewellbeing. |
| URL | https://www.predictmedix.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Analyst Coverage
|
Low:--
High:--
|
|
| Price Target Std Dev |
|
| Price Target Upside (Daily) | Upgrade |
| Price Target Num Estimates | Upgrade |
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Dividends
| Dividend Per Share (TTM) | -- |
|
2017
2018
2019
2020
2021
6.00%
4.00%
2.00%
|
|
| Yield to Market | 0.00 |
| Yield to Sector | 0.00 |
| Yield to Industry | -- |
| Last Dividend Amt. | -- |
| Dividend Frequency | -- |
| Last Ex-Dividend Date | -- |
| Yield (TTM) | 0% |
| Forward Yield | -- |
| Payout Ratio | 0.00% |
| Cash Payout Ratio | 0.00% |
| Consistent Payer (5Y) | No |
| Consistent Growth (5Y) | No |
Risk
Total Returns Comparison
Annual Total Returns Versus Peers
As of March 17, 2023.
Fundamentals
| Revenue (TTM) | 0.0648M |
| Total Expenses (TTM) | 1.831M |
| Net Income (TTM) | -1.766M |
| Total Assets (Quarterly) | 0.9498M |
| Total Liabilities (Quarterly) | 0.62M |
| Shareholders Equity (Quarterly) | 0.3297M |
| Cash from Operations (TTM) | -0.6264M |
| Cash from Investing (TTM) | -0.3027M |
| Cash from Financing (TTM) | 0.4618M |
Ratings
Profile
Edit
| Predictmedix Inc, through its subsidiaries, is in the business of investment in technology to detect if an individual is under the influence of cannabis and to predict substance addiction. It is currently focusing on artificial intelligence technologies, which are targeting two specific areas: workplace health & safety and healthcare. Its solutions include Infectious Disease Screening, Cannabis & Alcohol Impairment Screening, and Mobilewellbeing. |
| URL | https://www.predictmedix.com |
| Investor Relations URL | N/A |
| HQ State/Province | Ontario |
| Sector | Healthcare |
| Industry | Medical Devices |
| Equity Style | N/A |
| Next Earnings Release | N/A |
| Last Earnings Release | N/A |
| Next Ex-Dividend Date | N/A |
| Last Ex-Dividend Date | N/A |
Ownership
| Insider Ownership Percentage | Upgrade |
Jul '20
Nov '20
Mar '21
80.00%
40.00%
10.00%
Analyst Coverage
|
Low:--
High:--
|
|
| Price Target Std Dev |
|
| Price Target Upside (Daily) | Upgrade |
| Price Target Num Estimates | Upgrade |
|
Consensus Rating
|
|
|
Analyst Recommendation
|
|
Source: S&P Global
Other Resources
| Yahoo Finance | Insider Trading |
| Yahoo Finance | Institutional Ownership |
| TMX Money | Option Chain |
| SEC | SEC Filings |
| PMED.CX Tweets |